Sanofi and GlaxoSmithKline granted Indian approval for COVID-19 vaccine trial
For this year the company from Parijs could earn a total revenue around 37.63 billion euros. This is according to the average of the analysts' estimates. This is slightly more than 2021's revenue of 37.37 billion euros.
Historical revenues and results Sanofi-Aventis plus estimates 2021
The analysts expect for 2021 a net profit of 7.8 billion euros. For this year the consensus of Sanofi-Aventis 's result per share is a profit of 6.26 euros. With this the price/earnings-ratio is 13.91.
Huge dividend Sanofi-Aventis
Per share the analysts anticipate on a dividend of 3.29 euros per share. The dividend yield is then 3.78 percent. The average dividend yield of the pharmaceutical companies equals a low 1.39 percent.Newest target prices around 100 euros
The latest 3 recommendations for the pharmaceutical company were provided by Jefferies & Co., Goldman Sachs and Deutsche Bank .Sanofi-Aventis 's market value equals around 109.2 billion . -3
Historical stock prices Sanofi-Aventis
At 14.59 the stock trades 0.23 percent higher at 87.09 euros.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
